
    
      This is a double blinded, pilot placebo-controlled trial of two interventions compared to
      placebo to determine the effects individually of Metabolic Rheostat™ and Butyrate Ultra daily
      consumption for 8 weeks on glucose homeostasis in subjects with prediabetes. The entire study
      will last 10 weeks including screen. The study will include 20 subjects with prediabetes
      treated with Metabolic Rheostat™; 20 subjects with prediabetes treated with Butyrate Ultra
      and 20 subjects with prediabetes treated with placebo. Participants will take 6 capsules
      daily, two capsules three times per day 30 minutes prior to each meal for 56 days.
    
  